2026 Giorgio Walter Canonica: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	124	293	271	6	5	949	74510
Medicine	124	3166	2953	87	77	957	74604

Research.com Recognitions

2026 - Research.com Immunology in Italy Leader Award
2025 - Research.com Immunology in Italy Leader Award
2023 - Research.com Immunology in Italy Leader Award
2023 - Research.com Medicine in Italy Leader Award
2022 - Research.com Immunology in Italy Leader Award
2018 - Member of Academia Europaea

Overview

Giorgio Walter Canonica is affiliated with Humanitas University in Italy and has contributed extensively to the field of medicine, with a particular focus on pulmonary and respiratory medicine, immunology and allergy, dermatology, and surgery. Their scholarly output encompasses a significant body of work related to asthma, allergic rhinitis, respiratory diseases, and related therapeutic interventions.

The scientist's research spans several main topics, which include:

Asthma and respiratory diseases
Allergic Rhinitis and Sensitization
Respiratory and Cough-Related Research
Inhalation and Respiratory Drug Delivery
Dermatology and Skin Diseases
Chronic Obstructive Pulmonary Disease (COPD) Research
Sinusitis and nasal conditions

Key subfields of study relevant to Canonica's work are:

Physiology
Pulmonary and Respiratory Medicine
Immunology and Allergy
Dermatology
Surgery

Canonica has published in a variety of scientific journals, frequently contributing to:

Allergy
World Allergy Organization Journal
The Journal of Allergy and Clinical Immunology In Practice
Clinical and Translational Allergy
Zenodo (CERN European Organization for Nuclear Research)

The scientist's recent notable papers include:

"Allergic rhinitis" (2020) in Nature Reviews Disease Primers
"IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper" (2020) in World Allergy Organization Journal
"Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma" (2020) in Allergy
"EAACI Biologicals Guidelines-Recommendations for severe asthma" (2020) in Allergy
"Eosinophilic and Noneosinophilic Asthma" (2021) in CHEST Journal

Frequent coauthors collaborating with Canonica include:

Enrico Heffler
Giovanni Paoletti
Nikolaos G. Papadopoulos
Jean Bousquet
Francesca Puggioni

Canonica's scholarly contributions have been recognized by membership in the Academia Europaea since 2018. This affiliation confirms their involvement in the broader scientific community focused on medicine and related disciplines.

Best Publications

Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

J. Bousquet;H. J. Schünemann;B. Samolinski;P. Demoly

7892
Citations
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

J. Bousquet;N. Khaltaev;A. A. Cruz;J. Denburg

7223
Citations
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

Jan L. Brożek;Jean Bousquet;Ioana Agache;Arnav Agarwal

3155
Citations
The EAACI/GA 2 LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

T. Zuberbier;W. Aberer;R. Asero;C. Bindslev-Jensen

1675
Citations
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

M. Humbert;R. Beasley;J. Ayres;R. Slavin

1525
Citations
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Claus Bachert;Claus Bachert;Joseph K Han;Martin Desrosiers;Peter W Hellings

1450
Citations
Consensus statement * on the treatment of allergic rhinitis

P van Cauwenberge;C Bachert;G Passalacqua;J Bousquet

986
Citations
Practical guide to skin prick tests in allergy to aeroallergens

J. Bousquet;J. Bousquet;L. Heinzerling;C. Bachert;N. G. Papadopoulos

887
Citations
Standards for practical allergen-specific immunotherapy

E. Alvarez-Cuesta;J. Bousquet;G. W. Canonica;S. R. Durham

758
Citations
Allergen immunotherapy: therapeutic vaccines for allergic diseases

J. Bousquet;R. Lockey;H.J. Malling;E. Alvarez-Cuesta

679
Citations
Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009.

Canonica Gw;Bousquet J;Casale T;Lockey Rf

675
Citations
A survey of the burden of allergic rhinitis in Europe

Giorgio Canonica;J Bousquet;J Mullol;Gk Scadding

651
Citations
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Sarah K. Wise;Sandra Y. Lin;Elina Toskala;Richard R. Orlandi

613
Citations
Sublingual immunotherapy: World Allergy Organization position paper 2013 update

Giorgio Walter Canonica;Linda Cox;Ruby Pawankar;Carlos E Baena-Cagnani

592
Citations
Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce.

G. W. Canonica;C. E. Baena-Cagnani;J. Bousquet;P. J. Bousquet

576
Citations
A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics.

Giorgio Walter Canonica;Ignacio J Ansotegui;Ruby Pawankar;Peter Schmid-Grendelmeier

540
Citations
World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics

Alessandro Fiocchi;Ruby Pawankar;Carlos Cuello-Garcia;Carlos Cuello-Garcia;Kangmo Ahn

517
Citations
Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study.

V. Di Rienzo;F. Marcucci;P. Puccinelli;S. Parmiani

507
Citations
IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper.

Ignacio J. Ansotegui;Giovanni Melioli;Giorgio Walter Canonica;Luis Caraballo

507
Citations
Antiallergic drugs and the immune response. Interactions and possible clinical relevance.

G. W. Canonica;G. Ciprandi

506
Citations
Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma.

Christelle Doucet;Danièle Brouty-Boyé;Corine Pottin-Clémenceau;Giorgio Walter Canonica

447
Citations

Frequent Co-Authors

Giovanni Passalacqua University of Genoa

Giorgio Ciprandi University of Genoa

Jean Bousquet University of Montpellier

Enrico Heffler Humanitas University

Claus Bachert Karolinska Institute

Nikolaos G. Papadopoulos National and Kapodistrian University of Athens

Francesco Blasi University of Milan

Torsten Zuberbier Charité - University Medicine Berlin

Gianenrico Senna University of Verona

Pascal Demoly University of Montpellier

External Links

Wikipedia of Giorgio Walter Canonica Personal website of Giorgio Walter Canonica

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related healthcare degrees can open diverse career opportunities. Many students with a scientific background explore nursing to complement their expertise. If you’re starting without a nursing background, several online RN programs for non nurses offer flexible pathways to enter the nursing field efficiently.

Accelerated options like the easiest ABSN program to get into provide a fast track for individuals holding a bachelor’s degree in other disciplines who want to become registered nurses. These programs focus on essential nursing skills alongside foundational health sciences, often supporting careers that interface with immunology research and clinical practice.

For those beginning their nursing journey, the fastest and easiest LPN programs enable quick entry into practical nursing roles that may involve immune system patient care in various settings. These pathways lay groundwork before advancing to higher nursing positions.

Additionally, nurse practitioners play a vital role in healthcare research and specialized care. Exploring the what is the easiest NP program can help identify options that balance workload and program duration, making it more feasible to gain advanced clinical expertise.

By leveraging these online degree options, individuals passionate about immunology can build robust careers that blend clinical skills with scientific understanding, contributing meaningfully to healthcare and medical research.